Automed Technologies, Inc. v. Knapp Logistics & Automation, Inc.

382 F. Supp. 2d 1372, 2005 U.S. Dist. LEXIS 17485, 2005 WL 1981122
CourtDistrict Court, N.D. Georgia
DecidedAugust 1, 2005
Docket104CV1152WSD
StatusPublished
Cited by1 cases

This text of 382 F. Supp. 2d 1372 (Automed Technologies, Inc. v. Knapp Logistics & Automation, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Automed Technologies, Inc. v. Knapp Logistics & Automation, Inc., 382 F. Supp. 2d 1372, 2005 U.S. Dist. LEXIS 17485, 2005 WL 1981122 (N.D. Ga. 2005).

Opinion

ORDER

DUFFEY, District Judge.

This matter is before the Court on Plaintiff Automed Technologies, Inc.’s Motion to Compel Return of Inadvertently Produced Privileged Document and for an Order Precluding Use of or Reference to the Document or Information Therein [96], Defendants’ Brief in Opposition to Plaintiffs Motion to Compel Return of Inadvertently Produced Privileged Document [100], Plaintiff Automed Technologies, Inc.’s Supplementation of the Factual Record in Further Support of Motion to Compel Return of Inadvertently Produced Privilege Document [110] and Defendants’ Supplemental Brief in Opposition to Plaintiffs Motion to Compel Return of Inadvertently Produced Privileged Document [111]. 1

*1373 BACKGROUND

This is a patent infringement action in which a dispute has arisen regarding whether the attorney-client privilege applies to a document produced in discovery. The document at issue is an Invention Record and Assignment Form (the “Form”). The Form was produced pursuant to a subpoena served on Mr. Robert Barrett, outside counsel for Baxter International, Inc. (“Baxter”). Baxter was the holder of U.S. Patent No. 5,208,762 (the “ ’762 Patent”) which is the predecessor patent to U.S. Reissue Patent No. RE37,-829 (the “ ’829 Patent”), the patent at issue in this case. In 1998, Baxter sold certain assets to Plaintiff Automed Technologies, Inc. (“Automed”), including the ’762 Patent and the application which resulted issuance of the ’829 Patent.

Mr. Barrett worked on prosecution of the ’762 Patent for Baxter and in view of his involvement in the prosecution, Defendant Knapp Logistics and Automation GmbH (“Knapp US”) served a subpoena on Mr. Barrett to require the production of documents relating to the patent. Mr. Barrett produced several hundred pages of documents to counsel for Automed to review for privileged material before the documents were produced. The review was conducted and documents were produced, including the Form. As with other documents produced in the case, the documents from Mr. Barrett’s files, including the Form, were produced pursuant to a confidentiality order entered in the case. The order allows documents to be designated as confidential according to two different categories, each of which provides a different level of protection. Automed’s counsel designated the Form as “Highly Confidential,” the more restrictive confidentiality category. Counsel for Knapp U.S. wrote to Automed’s lawyers questioning the completeness of the form and challenging its confidentiality designation. Automed’s counsel represented that he had reviewed the Form, that all documents in Mr. Barrett’s possession had been produced, and that the Form’s confidentiality designation was appropriate.

The Form was thereafter used in three depositions, including the depositions of the co-inventor of the invention covered by the ’829 Patent and Automed’s patent prosecution counsel. Apparently neither of them indicated they were instructed to maintain the information in the Form as confidential. The Form also was used during the deposition of Mr. Barrett. Mr. Barrett did not recognize the Form specifically. He stated he “believe[d]” the Form was an “internal document, and as such probably would be an attorney-client privileged communication.” (Barrett Dep. at 111.) He did not know how the document was used by Baxter’s counsel or how the information in it was requested or for what purpose.

Several weeks later, on the basis of Mr. Barrett’s testimony, Automed declared that the Form was protected by the attorney-client privilege, stated it had been produced inadvertently and moved for the document to be returned. 2 On July 1, 2005, the Court met with counsel for the *1374 parties and discussed Automed’s motion for return of the document. The Court found it did not have sufficient information to determine if the Form was privileged and, accordingly, ordered that Automed be provided additional time to develop the facts surrounding the creation of the Form so that the Court could determine if the Form was protected by the attorney-client privilege. Accordingly, the Court gave the parties up through and including July 7, 2005, to submit additional evidence on this issue.

On July 7, 2005, Automed provided the Court with additional information about the Form and its use. The testimony of two individuals was provided: Kelly D. Eckel, outside litigation counsel for Au-tomed in this action, and Keith Goodale, one of the co-inventors of the invention covered by the ’829 Patent. Ms. Eckel’s testimony recites some procedural history of the Form’s production and provides some additional information concerning the Form’s use. Her testimony relies principally on information apparently reported to her regarding (i) Mr. Barrett, (ii) his understanding regarding the history, including ownership, of the ’762 and ’829 Patents, (iii) Automed’s counsel’s determination based on its review of the Form that it was not privileged and thus was produced to Knapp US, and (iv) the assertion of the attorney-client privilege following Mr. Barrett’s deposition. Ms. Eckel stated that, following the Court’s July 1, 2005 hearing, “Duane Morris undertook numerous steps in an attempt to discover more facts concerning [the Form], including contacting the Baxter legal department, but was unable to obtain any additional information regarding [the Form] from Baxter.” (Eckel Aff. ¶ 14.) 3

Automed also provided a transcript of Mr. Goodale’s deposition testimony. Mr. Goodale, a co-inventor of the invention covered by the ’762 Patent, was deposed on July 15, 2005, 4 and stated that: (1) he did not know who asked him to prepare the Form (Goodale Dep. at 9); (2) he did not know to whom he forwarded the Form (id. at 11); (3) he did not know who saw the form in addition to the other inventors who signed it (id.); (4) he did not know how the Form was used after he prepared it (id. at 12); (5) he was not told to keep the Form confidential or that he could not disclose it to anyone outside of Baxter (id. at 18); (6) his general understanding of the Form was that it was used “to put the idea with that was to be patented on record” the purpose of which was to “receive a patent for the invention,” “[t]o begin the process,” “[t]o have a record of the idea itself,” and “[t]o log the idea with the proper attorneys at Baxter to receive a patent.” (id. at 13, 14, 17, 19); and (7) when he signed the Form, he understood he was assigning to Baxter any rights he had in the invention at issue (id. at 17).

DISCUSSION

The attorney-client privilege necessarily tends to interfere with the discovery of the truth. Because of this effect, the privilege must be construed with its purpose, which is to encourage clients to communicate freely and opening with their attorneys by removing the fear that their discussions will be subject to disclosure. United States v. Suarez, 820 F.2d 1158 (11th Cir.1987); Shearing v. Iolab Corp.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
382 F. Supp. 2d 1372, 2005 U.S. Dist. LEXIS 17485, 2005 WL 1981122, Counsel Stack Legal Research, https://law.counselstack.com/opinion/automed-technologies-inc-v-knapp-logistics-automation-inc-gand-2005.